Published in J Virol on October 01, 1994
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 2.94
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection. J Virol (2002) 2.44
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol (2000) 1.94
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med (1998) 1.59
Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol (2005) 1.48
Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol (1998) 1.48
Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. J Virol (2007) 1.44
Early Loss of Splenic Tfh Cells in SIV-Infected Rhesus Macaques. PLoS Pathog (2015) 1.42
Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques. J Virol (2013) 1.21
Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol (1997) 1.17
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin Microbiol Rev (1996) 1.02
CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol (2007) 1.00
A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J Virol (1998) 0.99
Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression. J Virol (2003) 0.96
Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol (2008) 0.95
CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis. Front Immunol (2015) 0.90
Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection. J Virol (1996) 0.87
Acute SIV infection in sooty mangabey monkeys is characterized by rapid virus clearance from lymph nodes and absence of productive infection in germinal centers. PLoS One (2013) 0.78
CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads. J Infect Dis (2013) 0.78
CD4 T Follicular Helper Cells and HIV Infection: Friends or Enemies? Front Immunol (2017) 0.75
Divergent Expression of CXCR5 and CCR5 on CD4(+) T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection. Front Immunol (2017) 0.75
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (1993) 15.54
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (1993) 5.40
Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol (1993) 4.83
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol (1994) 3.71
Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis (1991) 3.16
Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet (1984) 3.01
Primary HIV infection: host responses and intervention strategies. AIDS (1991) 2.80
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A (1984) 2.73
Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol (1992) 2.37
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol (1989) 2.33
Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr (1990) 2.15
High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J Virol (1993) 1.93
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88
Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS (1993) 1.85
Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J Infect Dis (1988) 1.75
Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). Am J Pathol (1987) 1.54
Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization. Am J Pathol (1989) 1.52
Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals. Am J Pathol (1988) 1.48
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A (1994) 1.48
Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome. J Clin Invest (1986) 1.43
Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques. J Immunol (1992) 1.27
HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells. Am J Pathol (1990) 1.24
The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquir Immune Defic Syndr (1991) 1.18
The central role of follicular dendritic cells in lymphoid tissues. Adv Immunol (1992) 1.13
Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol (1994) 1.07
HIV and human complement: mechanisms of interaction and biological implication. Immunol Today (1993) 1.01
Postmortem localization of HIV-1 RNA by in situ hybridization in lymphoid tissues of intravenous drug addicts who died unexpectedly. Am J Pathol (1993) 0.86
High viral burden in lymph nodes during early stages of HIV-1 infection. AIDS (1993) 0.86
The pathobiology of HIV infection. Immunol Today (1992) 0.85
Variation in the CD4+ and CD8+ populations in lymph nodes does not reflect that in the blood during SIVMNE/E11S infection of macaques. J Med Primatol (1992) 0.85
Acute lymphoid changes and ongoing immune activation in SIV infection. J Acquir Immune Defic Syndr (1992) 0.84
Simian immunodeficiency virus (SIVsm) infection of cynomolgus monkeys: effects on follicular dendritic cells in lymphoid tissue. AIDS Res Hum Retroviruses (1992) 0.83
Follicular dendritic cells and their role in HIV infection. Immunol Today (1992) 0.82
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
HIV-1 genome nuclear import is mediated by a central DNA flap. Cell (2000) 5.87
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology (1991) 5.54
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (1987) 5.45
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature (1989) 5.12
Human immunodeficiency viruses. Science (1986) 4.34
Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science (1984) 4.02
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27
Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol (1989) 3.05
A possible subunit structure of Rous sarcoma virus RNA. J Gen Virol (1969) 2.96
Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 2.94
Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature (1987) 2.86
Apoptosis in AIDS. Science (1993) 2.86
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J (1987) 2.85
HIV/HTLV gene nomenclature. Nature (1988) 2.72
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56
VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J (1989) 2.45
The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43
The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS (1988) 2.35
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet (1998) 2.32
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med (1987) 2.32
Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23
Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (1984) 2.19
Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol (1992) 2.04
Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J Virol (1989) 1.97
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95
[Presence of a double chain ribonucleic acid in animal cells]. C R Acad Sci Hebd Seances Acad Sci D (1968) 1.94
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun (1984) 1.94
Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing. J Virol (1989) 1.93
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene (1990) 1.90
Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng (1988) 1.87
Inactivation, by UV-, x-, and gamma-radiations, of the infecting and transforming capacities of polyoma virus. Virology (1967) 1.86
A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retroviruses (1988) 1.80
The multitude and diversity of environmental carcinogens. Environ Res (2007) 1.73
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (1984) 1.73
AIDS in 1988. Sci Am (1988) 1.71
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A (1979) 1.66
Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet (1988) 1.66
Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS (1992) 1.65
Titration and circulation of cells mediating delayed type hypersensitivity in normal and cyclophosphamide treated mice during response to sheep red blood cells. Immunology (1978) 1.64
Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate. Lancet (1985) 1.60
Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet (1986) 1.58
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med (1984) 1.51
Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes. Lancet (1985) 1.48
Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology (1994) 1.46
Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42
Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology (1993) 1.41
Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur J Immunol (1990) 1.40
Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol (2007) 1.39
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
AIDS-associated mycoplasmas. Annu Rev Microbiol (1994) 1.34
Interferon messenger RNA: translation in heterologous cells. Proc Natl Acad Sci U S A (1972) 1.32
Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J Exp Med (1988) 1.31
Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother (2007) 1.29
Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection. J Med Primatol (2004) 1.29
Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. Proc Natl Acad Sci U S A (1975) 1.27
Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol (1991) 1.26
Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients. J Virol (1998) 1.26
Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers. J Virol (1990) 1.26
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25
Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Clin Exp Immunol (1979) 1.24
Kaposi's sarcoma and new herpesvirus. Lancet (1995) 1.24
Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Ann Immunol (Paris) (1980) 1.23
Homology of double stranded RNA from rat liver cells with cellular genome. Nat New Biol (1971) 1.22
The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res Hum Retroviruses (1996) 1.21
Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. Virology (1989) 1.20
Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin Immunol (1993) 1.20
Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines. Infect Immun (1992) 1.20
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. J Exp Med (1989) 1.20
HIV-2 antisera cross-neutralize HIV-1. AIDS (1988) 1.17
Cell surface expression of several species of human immunodeficiency virus type 1 major core protein. J Virol (1989) 1.14
Efficiency of poly(A).poly(U) as an adjuvant. Immunol Today (1988) 1.14
TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ (2007) 1.14
Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Ann N Y Acad Sci (1999) 1.14
Influence of microbial infections on the progression of HIV disease. Trends Microbiol (1997) 1.14
Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology (1995) 1.13
Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation. J Pediatr (1986) 1.13
Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice. Infect Immun (1981) 1.13
The chronology of AIDS research. Nature (1987) 1.12
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Am J Med (1986) 1.11
What to call the AIDS virus? Nature (1986) 1.11
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol (1993) 1.10
Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease. J Bacteriol (1997) 1.10
A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection. J Acquir Immune Defic Syndr (1990) 1.10